# First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis

> **NCT00875446** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 76 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** PLACEBO
- **DRUG:** GSK1223249

## Key facts

- **NCT ID:** NCT00875446
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05-13
- **Primary completion:** 2011-09-09
- **Final completion:** 2011-09-09
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2017-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00875446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00875446, "First Time in Human Study of GSK1223249 in Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00875446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*